Research progress of FcRn antagonists in the treatment of IgG-mediated neuroimmune diseases
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2025, Vol 51, Issue 1
Abstract
The neonatal Fc receptor (FcRn) prolongs the half-life of immunoglobulin G (IgG) and promotes its recycling by binding to and making it an important receptor for maintaining serum IgG homeostasis. However, the abnormal accumulation of pathogenic IgG is closely related to the occurrence of various neuroimmune diseases. FcRn antagonists can significantly reduce the level of pathogenic IgG by blocking the binding of FcRn to IgG, thereby effectively alleviating the clinical symptoms of related diseases. As an emerging targeted therapeutic drug, FcRn antagonists have shown their potential in treating IgG-mediated neuroimmune diseases. This article summarizes the mechanism of action,types and clinical research progress of FcRn antagonists with the aim of providing new ideas for the precise treatment of IgG-mediated neuroimmune diseases. Future research should focus on the long-term safety of drugs, expansion of indications and individualized treatment strategies to further enhance their clinical application value.
Authors and Affiliations
Xiaohuan ZHU, Wenshuang ZENG, Haibing XIAO, Huiting LIN, Lina. LI
An intervention study of Orff-music therapy for long-term hospitalized patients with schizophrenia
[Objective] This research aims to investigate the impact of Orff music therapy on long-term schizophrenic patients in hospitals. [Methods] The study was a randomized, single-blind controlled trial conducted from April,20...
Chinese expert consensus on neurosurgical treatment of psychiatric disorders
Chinese expert consensus on neurosurgical treatment of psychiatric disorders is compiled by national experts in neurosurgery, psychiatry, and other related fields. Based on clinical research published up to December 2023...
A fragile X syndrome family with epilepsy
Fragile X syndrome (FXS) is caused by abnormal duplication and amplification of the FMR1 gene CGG. This article reports a pair of brothers diagnosed with FXS by genetic testing. Two patients, aged 15 and 14 years old res...
A case report of type II citrullinemia in an adult with epileptic seizure onset
A retrospective analysis was performed on one case of adult-onset type â…¡citrullinemia (CTLN2) caused by homozygous mutations of SLC25A13 genes. The patient, a 28-year-old male, had repeated limb convulsions for more than...
Inhibitory control subcomponent characteristics of children with autism spectrum disorder aged 4-5 years
[Objective] To comprehensively investigate the subcomponent characteristics of inhibitory control for children with autism spectrum disorder (ASD) aged 4-5 years under experimental and natural environments. [Methods] Thi...